Taro Pharma (TARO) Reports Q2 EPS of $3.00
Tweet
Share
E-mailGet Alerts TARO Hot Sheet
Join SI Premium – FREE
Taro Pharma (NYSE: TARO) reported Q2 EPS of $3.00, versus $3.11 reported last year. Revenue for the quarter came in at $228.8 million, versus $212.06 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) tops Q1 EPS by 3c; misses on guidance
- Avalonbay Communities (AVB) Tops Q1 EPS by 5c
- Eastman Chemical (EMN) Tops Q1 EPS by 18c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
